Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restriction

被引:57
作者
CallesEscandon, J
Ballor, D
HarveyBerino, J
Ades, P
Tracy, R
Sobel, B
机构
[1] UNIV VERMONT, COLL MED, DEPT INTERNAL MED, BURLINGTON, VT 05405 USA
[2] UNIV VERMONT, COLL MED, DEPT HUMAN DEV STUDIES, BURLINGTON, VT 05405 USA
[3] UNIV VERMONT, COLL MED, DEPT FOOD SCI & HUMAN NUTR, BURLINGTON, VT 05405 USA
[4] UNIV VERMONT, COLL MED, DEPT PATHOL, BURLINGTON, VT 05405 USA
[5] UNIV VERMONT, COLL MED, DEPT BIOCHEM, BURLINGTON, VT 05405 USA
关键词
atherosclerosis; obesity; coronary disease; elderly people; PLASMINOGEN-ACTIVATOR INHIBITOR; LINKED IMMUNOSORBENT-ASSAY; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; FACTOR-VII; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; ABDOMINAL OBESITY; VENOUS OCCLUSION; SEDENTARY MEN;
D O I
10.1093/ajcn/64.1.7
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
A possible cause of accelerated atherothrombosis in the syndrome of insulin resistance appears to be an elevated blood concentration of Plasminogen activator inhibitor type-1 (PAI-1). Insulin resistance occurs with aging, attributable partly to increased adiposity. Scarce information exists regarding the effects of weight loss in elderly, obese individuals on PAI-1 concentrations. Consequently, weight loss (9 +/- 1 kg) was induced by energy intake restriction in 19 elderly, obese individuals, and its effect on fibrinolytic system peptides was measured. Initially elevated PAI-1 concentrations decreased by 50%, with a simultaneous decrease in the concentration of tissue-type plasminogen activator (t-PA)/PAI-1 complexes but no significant change in t-PA suggested a decrease in inhibition of the fibrinolytic system. The concentration of plasmin/antiplasmin complexes (PAP complex) increased by approximate to 20%, indicating augmented fibrinolytic system activity. The decline in PAI-1 correlated with that of the decrease in body weight (r = 0.5, P < 0.05) and fat mass losses (r = 0.46, P < 0.05). The increase in PAP complexes correlated with weight and fat mass losses (r = 0.4 and r = 0.46, respectively; P < 0.05 for both). No correlation was seen between fibrinolytic system variables and baseline concentrations of substrates or insulin, but the change in PAI-1 correlated with the change in plasma triacylglycerols (r = 0.58, P < 0.05). Results indicate that energy restriction sufficient to induce moderate weight loss leads to diminution of elevated plasma PAI-1 and relief of inhibition of the fibrinolytic system in elderly, obese subjects. To the extent that these changes are associated with a decrease in the progression of vasculopathy, weight loss in elderly, obese individuals may be a useful means to reduce cardiovascular morbidity and mortality.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 53 条
[1]   CORRELATIONS BETWEEN T-PA AND PAI-1 ANTIGEN AND ACTIVITY AND T-PA/PAI-1 COMPLEXES IN PLASMA OF CONTROL SUBJECTS AND OF PATIENTS WITH INCREASED T-PA OR PAI-1 LEVELS [J].
ALESSI, MC ;
JUHANVAGUE, I ;
DECLERCK, PJ ;
ANFOSSO, F ;
GUEUNOUN, E ;
COLLEN, D .
THROMBOSIS RESEARCH, 1990, 60 (06) :509-516
[2]   RELATIONSHIP BETWEEN PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY AND VLDL TRIGLYCERIDE CONCENTRATION, INSULIN LEVELS AND INSULIN SENSITIVITY - STUDIES IN RANDOMLY SELECTED NORMOTRIGLYCERIDAEMIC AND HYPERTRIGLYCERIDEMIC MEN [J].
ASPLUNDCARLSON, A ;
HAMSTEN, A ;
WIMAN, B ;
CARLSON, LA .
DIABETOLOGIA, 1993, 36 (09) :817-825
[3]   TISSUE-TYPE PLASMINOGEN-ACTIVATOR ANTIGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR IN DIABETES-MELLITUS [J].
AUWERX, J ;
BOUILLON, R ;
COLLEN, D ;
GEBOERS, J .
ARTERIOSCLEROSIS, 1988, 8 (01) :68-72
[4]   EFFECT OF WEIGHT-LOSS ON COAGULATION FACTOR-VII AND FACTOR-X [J].
BARON, JA ;
MANN, J ;
STUKEL, T .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (08) :519-522
[5]   EFFECTS OF AGE AND BODY-FAT ON INSULIN RESISTANCE IN HEALTHY-MEN [J].
BODEN, G ;
CHEN, XH ;
DESANTIS, RA ;
KENDRICK, Z .
DIABETES CARE, 1993, 16 (05) :728-733
[6]   INCREASED FIBRIN TURNOVER AND HIGH PAI-1 ACTIVITY AS PREDICTORS OF ISCHEMIC EVENTS IN ATHEROSCLEROTIC PATIENTS - A CASE-CONTROL STUDY [J].
CORTELLARO, M ;
COFRANCESCO, E ;
BOSCHETTI, C ;
MUSSONI, L ;
DONATI, MB ;
CARDILLO, M ;
CATALANO, M ;
GABRIELLI, L ;
LOMBARDI, B ;
SPECCHIA, G ;
TAVAZZI, L ;
TREMOLI, E ;
POZZOLI, E ;
TURRI, M ;
CORTELLARO, M ;
COFRANCESCO, E ;
BOSCHETTI, C ;
CARDILLO, M ;
TORRI, M ;
RAINISIO, M ;
GENTILE, G ;
MOREO, G ;
BIANCHI, O ;
LEONARDI, P ;
COLOMBI, M ;
CATALANO, M ;
GALIMBERTI, P ;
RUSSO, U ;
CRESSOTTI, A ;
CARZANIGA, G ;
NOBILI, S ;
NINNO, D ;
DONATI, MB ;
IACOVIELLO, L ;
DEGAETANO, G ;
GABRIELLI, L ;
MARTELLI, E ;
CORSI, G ;
LORENZI, G ;
LOMBARDI, B ;
CARRIERO, MR ;
COLOMBO, R ;
SPECCHIA, G ;
CIOFFI, P ;
SCIRE, A ;
TAVAZZI, L ;
GIANNUZZI, P ;
CORRA, U ;
TEMPORELLI, L ;
MORA, F .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (10) :1412-1417
[7]  
DECLERCK PJ, 1988, BLOOD, V71, P220
[8]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[9]   FIBRINOGEN IN OBESITY BEFORE AND AFTER WEIGHT-REDUCTION [J].
DITSCHUNEIT, HH ;
FLECHTNERMORS, M ;
ADLER, G .
OBESITY RESEARCH, 1995, 3 (01) :43-48
[10]  
ERNST E, 1989, INT J OBESITY, V13, P167